Extra-short vs. Non-extra-short Dental Implants Splinted on the Same Prosthesis

NCT ID: NCT04927819

Last Updated: 2025-04-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

102 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-11

Study Completion Date

2025-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim of this prospective study is to analyze the survival rate of short-length implants (\<6.5 mm) in subjects with partial edentulism. Non-short length implant will be used as control arm. Additionally, others clinical parameters (marginal bone loss and prosthetic associated complications) will be measured.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Partial-edentulism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

short-length implant (<6.5 mm)

BTI Implant

Intervention Type DEVICE

BTI Dental implants are non-active medical device, single use, non resterilizable, biocompatible and sterile devices made of alloplastic materials (Titanium) intended to be surgically implanted into alveolar and/or basal bone of the mandible or maxilla to provide support and a means of retention for a dental prosthesis (e.g. bridge, single-tooth, overdenture).

non-short length implant (≥6.5 mm)

BTI Implant

Intervention Type DEVICE

BTI Dental implants are non-active medical device, single use, non resterilizable, biocompatible and sterile devices made of alloplastic materials (Titanium) intended to be surgically implanted into alveolar and/or basal bone of the mandible or maxilla to provide support and a means of retention for a dental prosthesis (e.g. bridge, single-tooth, overdenture).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BTI Implant

BTI Dental implants are non-active medical device, single use, non resterilizable, biocompatible and sterile devices made of alloplastic materials (Titanium) intended to be surgically implanted into alveolar and/or basal bone of the mandible or maxilla to provide support and a means of retention for a dental prosthesis (e.g. bridge, single-tooth, overdenture).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Have planned a fixed multiple prosthesis supported by implants \<6.5 mm in length and implants ≥ 6.5 mm in length within 15 days before the inclusion of the patient in the study.
* Planning of supported prostheses from 2 to 4 implants dental
* Have a previously performed CBCT (Cone Beam Computed Tomography)
* Availability to be observed during the period of tracing
* Signature of the informed consent

Exclusion Criteria

* Smokers\> 10 cigarettes / day
* Complete prostheses
* Unitary prostheses
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundación Eduardo Anitua

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eduardo Anitua, MD

Role: PRINCIPAL_INVESTIGATOR

Clinica Eduardo Anitua

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinica Eduardo Anitua

Vitoria-Gasteiz, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mikel Allende, PhD

Role: CONTACT

+34945160653 ext. 257

Mikel Allende

Role: CONTACT

+34945160653 ext. 257

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mikel Allende

Role: primary

+34945160653

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FIBEA_02_EP/20/Extracortos

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immediate Loading in Single Tooth Implants
NCT05409287 ACTIVE_NOT_RECRUITING NA